SCC - SQUAMOUS CELL CARCINOMA
Clinical trials for SCC - SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SCC - SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SCC - SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection combo shows promise against head and neck cancer
Disease control Recruiting nowThis early-stage trial tests a new drug, VLPONC-01, injected directly into tumors in people with head and neck cancer. The study aims to see if it is safe and whether combining it with an immunotherapy drug (pembrolizumab) can shrink tumors better than the immunotherapy alone. Ab…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called MQ710, a modified virus injected directly into tumors, alone or with the immunotherapy drug pembrolizumab. It is for people with advanced solid tumors (like skin cancer or head and neck cancer) that have not responded to standar…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New PET tracer could slash unnecessary biopsies for head and neck cancer patients
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]NOTA-ABY030, which is designed to make head and neck squamous cell carcinoma show up more clearly on PET/CT scans. About 25 adults with suspicious or unclear findings on standard scans will receive the tracer and b…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 10, 2026 13:29 UTC
-
New scanner could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a high-resolution PET-CT scanner that images removed tumors right in the operating room. About 50 adults with solid cancers will get a standard PET tracer before surgery, then the removed tissue is scanned to see if all cancer was taken out. The goal is to see if…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:57 UTC
-
Blood test may predict cancer return after radiation
Knowledge-focused Recruiting nowThis study is for people with advanced head and neck cancer (stage III or IV) who are getting radiation therapy. Researchers want to see if measuring tiny bits of tumor DNA in the blood one month after treatment can help predict whether the cancer will come back within two years.…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Knowledge-focused Recruiting nowThis early-phase study tests a fluorescent dye attached to the cancer drug panitumumab to make head and neck cancer cells glow during surgery. About 18 adults scheduled for curative surgery will receive the dye infusion before their operation. The main goal is to find the best do…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:12 UTC